18.16USDMkt Cap: 800.73M USDP/E: 10.94Last update: 2026-05-21
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. I…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Company
Market Cap800.73M USD
Enterprise Value1.20B USD
Revenue (TTM)720.53M USD
Gross Profit356.06M USD
Net Income (TTM)98.09M USD
Revenue/Share15.61 USD
Last Price18.16 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS03209R1032
Valuation
P/E (Trailing)10.94
P/E (Forward)5.54
PEG—
EV/EBITDA6.06
EV/Revenue1.66
P/S1.11
P/B1.05
EPS (TTM)1.66
EPS (Forward)3.28
52W Range
17.7765% of range18.37
52W High18.37 USD
52W Low17.77 USD
Profitability
Gross Margin49.46%
Oper. Margin7.96%
EBITDA Margin27.38%
Profit Margin13.63%
ROE12.44%
ROA6.02%
Growth
Revenue Growth0.40%
Earnings Growth-72.50%
Cash Flow & Leverage
Operating CF156.12M USD
CapEx (TTM)37.13M USD
FCF Margin14.31%
FCF Yield12.88%
Net Debt394.43M USD
Net Debt/EBITDA2.00
Balance Sheet
Debt/Equity0.83
Current Ratio3.85
Quick Ratio2.73
Book Value/Sh17.28 USD
Cash/Share6.621 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)23.33 USD
Target Range19.00 USD – 30.00 USD
# Analysts6
Ownership
Shares Out.44.09M
Float32.84M
Insiders29.63%
Institutions76.39%
Short Interest
Short Ratio8.2d
Short % Float16.67%
Short % Out.8.05%
Shares Short3.59M
Short (prev mo.)3.53M
Technical
SMA 5020.21 (-10.1%)
SMA 20024.93 (-27.2%)
Beta0.97
S&P 52W Chg28.31%
Avg Vol (30d)1.59M
Avg Vol (10d)1.11M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—